{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T19:57:44Z","timestamp":1784231864341,"version":"3.55.0"},"reference-count":54,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2013,7,25]],"date-time":"2013-07-25T00:00:00Z","timestamp":1374710400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"DOI":"10.1371\/journal.ppat.1003456","type":"journal-article","created":{"date-parts":[[2013,7,25]],"date-time":"2013-07-25T22:16:35Z","timestamp":1374790595000},"page":"e1003456","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":18,"title":["A Multi-targeted Drug Candidate with Dual Anti-HIV and Anti-HSV Activity"],"prefix":"10.1371","volume":"9","author":[{"given":"Jan","family":"Balzarini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graciela","family":"Andrei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Balestra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Huskens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Vanpouille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Introini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Zicari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Liekens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Snoeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton\u00edn","family":"Hol\u00fd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo-Federico","family":"Perno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonid","family":"Margolis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Schols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,7,25]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"S240","DOI":"10.1086\/422361","article-title":"Calculating the contribution of herpes simplex virus type 2 epidemics to increasing HIV incidence: treatment implications","volume":"39, Suppl 5","author":"S Blower","year":"2004","journal-title":"Clin Infect Dis"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1056\/NEJMe068302","article-title":"Synergistic copathogens\u2013HIV-1 and HSV-2","volume":"356","author":"L Corey","year":"2007","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3410\/M2-41","article-title":"Can we reduce the spread of HIV infection by suppressing herpes simplex virus type 2 infection?","volume":"2","author":"A Buv\u00e9","year":"2010","journal-title":"F1000 Med Rep"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/01.aids.0000198081.09337.a7","article-title":"Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies","volume":"20","author":"EE Freeman","year":"2006","journal-title":"AIDS"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"e1002109","DOI":"10.1371\/journal.ppat.1002109","article-title":"HSV-2 infection of dendritic cells amplifies a highly susceptible HIV-1 cell target","volume":"7","author":"E Martinelli","year":"2011","journal-title":"PLoS Pathog"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1001\/jama.280.1.61","article-title":"Frequent recovery of HIV-1 from genital herpes simplex virus lesions in HIV-1-infected men","volume":"280","author":"T Schacker","year":"1998","journal-title":"JAMA"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/353709c0","article-title":"Mucosal transmission of HIV","volume":"353","author":"T Lehner","year":"1991","journal-title":"Nature"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1084\/jem.183.1.215","article-title":"Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques","volume":"183","author":"AI Spira","year":"1996","journal-title":"J Exp Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1006\/viro.2000.0667","article-title":"Herpes simplex virus infection induces replication of human immunodeficiency virus type 1","volume":"278","author":"M Moriuchi","year":"2000","journal-title":"Virology"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1128\/AAC.37.2.332","article-title":"Differential antiherpesvirus and antiretrovirus effects of the (S) and (R) enantiomers of acyclic nucleoside phosphonates: potent and selective in vitro and in vivo antiretrovirus activities of (R)-9-(2-phosphonomethoxypropyl)-2,6-diaminopurine","volume":"37","author":"J Balzarini","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"5716","DOI":"10.1073\/pnas.74.12.5716","article-title":"Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine","volume":"74","author":"GB Elion","year":"1977","journal-title":"Proc Natl Acad Sci US A"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1056\/NEJMoa062607","article-title":"Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus","volume":"356","author":"N Nagot","year":"2007","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/QAD.0b013e32831db217","article-title":"Impact of aciclovir on genital and plasma HIV-1 RNA in HSV-2\/HIV-1 co-infected women: a randomized placebo-controlled trial in South Africa","volume":"23","author":"S Delany","year":"2009","journal-title":"AIDS"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1097\/QAD.0b013e328347fa37","article-title":"Meta-analysis of randomized trials on the association of prophylactic acyclovir and HIV-1 viral load in individuals coinfected with herpes simplex virus-2","volume":"25","author":"C Ludema","year":"2011","journal-title":"AIDS"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1093\/infdis\/jir649","article-title":"High-dose valacyclovir HSV-2 suppression results in greater reduction in plasma HIV-1 levels compared with standard dose acyclovir among HIV-1\/HSV-2 coinfected persons: a randomized, crossover trial","volume":"204","author":"K Mugwanya","year":"2011","journal-title":"J Infect Dis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1126\/science.1193748","article-title":"Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women","volume":"329","author":"Q Abdool Karim","year":"2010","journal-title":"Science"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0140-6736(10)61200-7","article-title":"After CAPRISA 004: time to re-evaluate the HIV lexicon","volume":"376","author":"W Cates Jr","year":"2010","journal-title":"Lancet"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.chom.2008.07.008","article-title":"Acyclovir is activated into a HIV-1 reverse transcriptase inhibitor in herpesvirus-infected human tissues","volume":"4","author":"A Lisco","year":"2008","journal-title":"Cell Host Microbe"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.chom.2011.08.015","article-title":"Topical tenofovir, a microbicide effective against HIV, inhibits herpes simplex virus-2 replication","volume":"10","author":"G Andrei","year":"2011","journal-title":"Cell Host Microbe"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0166-3542(87)80004-9","article-title":"Antiviral activity of phosphonylmethoxyalkyl derivatives of purine and pyrimidines","volume":"8","author":"E De Clercq","year":"1987","journal-title":"Antiviral Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1128\/AAC.32.7.1025","article-title":"Phosphonylmethoxyethyl purine derivatives, a new class of anti-human immunodeficiency virus agents","volume":"32","author":"R Pauwels","year":"1988","journal-title":"Antimicrob Agents Chemother"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0166-3542(93)90050-S","article-title":"Inhibitory effect of 9-(2-phosphonylmethoxyethyl)-adenine (PMEA) on human and duck hepatitis B virus infection","volume":"21","author":"RA Heijtink","year":"1993","journal-title":"Antiviral Res"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/353709c0","article-title":"Mucosal transmission of HIV","volume":"353","author":"T Lehner","year":"1991","journal-title":"Nature"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nprot.2008.245","article-title":"Use of human tissue explants to study human infectious agents","volume":"4","author":"JC Grivel","year":"2009","journal-title":"Nat Protoc"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/jac\/dkl454","article-title":"Pronounced in vitro and in vivo antiretroviral activity of 5-substituted 2,4-diamino-6-[2-(phosphonomethoxy)ethoxy] pyrimidines","volume":"59","author":"J Balzarini","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1258\/ijsa.2012.011356","article-title":"Herpes simplex virus and HIV: genital infection synergy and novel approaches to dual prevention","volume":"23","author":"AR Thurman","year":"2012","journal-title":"Int J STD AIDS"},{"key":"ref27","first-page":"123","article-title":"Effect of beta-chemokines on human immunodeficiency virus type 1 replication, binding, uncoating, and CCR5 receptor expression in human monocyte-derived macrophages","volume":"2","author":"Y Jiang","year":"1999","journal-title":"J Hum Virol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.4049\/jimmunol.164.3.1582","article-title":"Retrovirally mediated IFN-beta transduction of macrophages induces resistance to HIV, correlated with up-regulation of RANTES production and down-regulation of C-C chemokine receptor-5 expression","volume":"164","author":"I Cremer","year":"2000","journal-title":"J Immunol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1034\/j.1601-0825.2002.00014.x","article-title":"The role of immunity in protection from mucosal SIV infection in macaques","volume":"8, Suppl 2","author":"LA Bergmeier","year":"2002","journal-title":"Oral Dis"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"5067","DOI":"10.1128\/JVI.00055-09","article-title":"Selection of a simian-human immunodeficiency virus strain resistant to a vaginal microbicide in macaques","volume":"83","author":"DM Dudley","year":"2009","journal-title":"J Virol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1365-2249.2002.01894.x","article-title":"Spontaneous production of RANTES and antigen-specific IFN-gamma production in macaques vaccinated with SHIV-4 correlates with protection against SIVsm challenge","volume":"129","author":"RK Ahmed","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"e1003148","DOI":"10.1371\/journal.ppat.1003148","article-title":"Interleukin-7 facilitates HIV-1 transmission to cervico-vaginal tissue ex vivo","volume":"9","author":"A Introini","year":"2013","journal-title":"PLoS Pathog"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1084\/jem.177.6.1809","article-title":"Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells","volume":"177","author":"DD Taub","year":"1993","journal-title":"J Exp Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1124\/jpet.103.055632","article-title":"Cross talk between P2Y2 nucleotide receptors and CXC chemokine receptor 2 resulting in enhanced Ca2+ signaling involves enhancement of phospholipase C activity and is enabled by incremental Ca2+ release in human embryonic kidney cells","volume":"307","author":"TD Werry","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.antiviral.2009.07.013","article-title":"The candidate sulfonated microbicide, PRO 2000, has potential multiple mechanisms of action against HIV-1","volume":"84","author":"D Huskens","year":"2009","journal-title":"Antiviral Res"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/QAD.0b013e32834541d9","article-title":"Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in women","volume":"25","author":"SS Abdool Karim","year":"2011","journal-title":"AIDS"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/095632020101200301","article-title":"Cytokines and HIV-1: interactions and clinical implications","volume":"12","author":"K Kedzierska","year":"2001","journal-title":"Antivir Chem Chemother"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/rmv.369","article-title":"The influence of cytokines, chemokines and their receptors on HIV-1 replication in monocytes and macrophages","volume":"13","author":"K Kedzierska","year":"2003","journal-title":"Rev Med Virol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1046\/j.1365-2567.2000.00993.x","article-title":"Up-regulation of beta-chemokines and down-modulation of CCR5 co-receptors inhibit simian immunodeficiency virus transmission in non-human primates","volume":"99","author":"T Lehner","year":"2009","journal-title":"Immunology"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"4825","DOI":"10.1182\/blood-2005-06-2463","article-title":"Long-lasting CCR5 internalization by antibodies in a subset of long-term nonprogressors: a possible protective effect against disease progression","volume":"107","author":"C Pastori","year":"2006","journal-title":"Blood"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"10411","DOI":"10.1073\/pnas.1834278100","article-title":"Rapamycin causes down-regulation of CCR5 and accumulation of anti-HIV beta-chemokines: an approach to suppress R5 strains of HIV-1","volume":"100","author":"A Heredia","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"e9310","DOI":"10.1371\/journal.pone.0009310","article-title":"In vitro and ex vivo testing of tenofovir shows it is effective as an HIV-1 microbicide","volume":"5","author":"LC Rohan","year":"2010","journal-title":"PLoS One"},{"key":"ref43","unstructured":"Schwartz JL, Rountree R, Kashuba A, et al.. (2009) A multi-compartment, single and multiple dose pharmacokinetic study of the candidate vaginal microbicide 1% tenofovir gel. 5<sup>th<\/sup> IAS Conference on HIV Pathogenesis, Treatment and Prevention, Cape Town, South Africa, 19\u201322 July 2009, Abstract LBDECO3."},{"key":"ref44","doi-asserted-by":"crossref","first-page":"4671","DOI":"10.1128\/AAC.49.11.4671-4680.2005","article-title":"Organotypic epithelial raft cultures as a model for evaluating compounds against alphaherpesviruses","volume":"49","author":"G Andrei","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/978-1-59745-170-3_26","article-title":"Measuring HIV neutralization in a luciferase reporter gene assay","volume":"485","author":"DC Montefiori","year":"2009","journal-title":"Methods Mol Biol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1128\/AAC.46.7.2185-2193.2002","article-title":"Antiretrovirus activity of a novel class of acyclic pyrimidine nucleoside phosphonates","volume":"46","author":"J Balzarini","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1021\/jm011095y","article-title":"6-[2-(Phosphonomethoxy)alkoxy]pyrimidines with antiviral activity","volume":"45","author":"A Hol\u00fd","year":"2002","journal-title":"J Med Chem"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1099\/0022-1317-81-3-639","article-title":"Resistance of herpes simplex virus type 1 against different phosphonylmethoxyalkyl derivatives of purines and pyrimidines due to specific mutations in the viral DNA polymerase gene","volume":"81","author":"G Andrei","year":"2000","journal-title":"J Gen Virol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0024-3205(01)01213-9","article-title":"The potency of acyclovir can be markedly different in different cell types","volume":"69","author":"G Brand","year":"2001","journal-title":"Life Sci"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jviromet.2008.11.013","article-title":"A highly sensitive and dynamic immunofluorescent cytometric bead assay for the detection of HIV-1 p24","volume":"157","author":"A Biancotto","year":"2009","journal-title":"J Virol Methods"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"4402","DOI":"10.1128\/JVI.75.9.4402-4406.2001","article-title":"The LD78beta isoform of MIP-1alpha is the most potent CC-chemokine in inhibiting CCR5-dependent human immunodeficiency virus type 1 replication in human macrophages","volume":"75","author":"S Aquaro","year":"2001","journal-title":"J Virol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"24845","DOI":"10.1074\/jbc.M110.128546","article-title":"Microvirin, a novel alpha(1,2)-mannose-specific lectin isolated from Microcystis aeruginosa, has anti-HIV-1 activity comparable with that of cyanovirin-N but a much higher safety profile","volume":"285","author":"D Huskens","year":"2010","journal-title":"J Biol Chem"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1128\/AAC.49.3.1177-1180.2005","article-title":"Novel acyclic nucleoside phosphonate analogues with potent anti-hepatitis B virus activities","volume":"49","author":"C Ying","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"12101","DOI":"10.1074\/jbc.M109.096529","article-title":"The acyclic 2,4-diaminopyrimidine nucleoside phosphonate acts as a purine mimetic in HIV-1 reverse transcriptase DNA polymerization","volume":"285","author":"BD Herman","year":"2010","journal-title":"J Biol Chem"}],"container-title":["PLoS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.ppat.1003456","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T04:33:02Z","timestamp":1646195582000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1003456"}},"subtitle":[],"editor":[{"given":"Guido","family":"Silvestri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,7,25]]},"references-count":54,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2013,7,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1003456","relation":{},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,25]]}}}